Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
Hser
Y I
YI
Neuropsychiatric Institute, University of California, Los Angeles 90024-3511.
Anglin
M D
MD
D003362:Cost-Benefit Analysis; D003430:Cross-Sectional Studies; D006302:Health Services Research / Q000379:methods* / Q000592:standards; D006801:Humans; D008137:Longitudinal Studies; D015233:Models, Statistical; D012107:Research Design / Q000592:standards; D019966:Substance-Related Disorders / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D013597:Systems Analysis; D016896:Treatment Outcome